Articles
Pharma Peers Unite to Build DNA-Encoded Libraries
Finding tools and hits for targets in drug discovery can feel like hunting for four leaf clovers in a blizzard. And researcher Sylvie Sakata was close to giving up on one discovery tool, DNA-encoded libraries, when a new consortium started to fall into place. Now this technology is garnering more interest for its potential to discover new molecular compounds, known as “hits,” to exponentially impact the early research efforts that can lead to potential new medicines.Sakata is the Head of....
What You Need to Know About a Promising Vaccine Candidate that May Stem the Growing Risk of Lyme Disease
Lyme disease is the most common vector-borne illness in the United States.1 The U.S. Centers for Disease Control and Prevention (CDC) says that state health departments reported over 63,000 cases in 2022.2 However, the CDC uses other methods to estimate that approximately 476,000 people in the U.S. may be diagnosed and treated for Lyme disease annually.2In other words, the estimated number of Lyme disease cases in the U.S. seems to be much higher than what is being reported to public health....
A New Road to Migraine Relief
Migraine, a debilitating neurological disorder,1 affects over a billion people globally.2,3 The cause of migraine remains an active area of research–experts believe genetics, the nervous system, and the brain's blood vessels are involved in the condition.4,5 The majority of people have episodic migraine, experiencing between 0-14 days of headache per month.6 On the other hand, those with chronic migraine experience 15 or more days of headaches a month, with at least 8 of those days caused by....
Clinical Trial Innovation: Putting the Patient First in Clinical Trial Design
Every day, across the United States and around the world, scientists are developing potential new medicines and vaccines that could change lives. But to get medicines and vaccines to the patients who need them most, they must first undergo a clinical trial, which is a research study that seeks to understand how potential medicines and other medical treatments work.These studies depend on the generosity of participants, who volunteer to be a part of the trial. Depending on the type of trial....
How Climate Change is Affecting the Spread of Lyme Disease—and 5 Things You Need to Know About the Disease
As the weather gets warmer, many of us will be spending more time outside, indulging in our favorite summer activities—and exposing ourselves to the elements, including a booming tick population. The incidence of Lyme disease has more than doubled over the last 24 years1 because populations of disease-carrying Ixodes ticks, better known as black-legged or deer ticks, have increased and expanded their ranges.2You don’t need to cancel summer adventures, but understanding ticks, the impact of....
An Accord for a Healthier World: Working Together to Help Address Unmet Healthcare Needs in Lower-Income Countries
Currently, regulatory agencies may take up to seven years to approve essential medicines and vaccines in low- and middle-income counties (LMICs) from the time those same treatments were first approved in high-income countries, if they are approved at all.1 The burden remains disproportionately higher in low-income countries.2 Lack of access to quality healthcare is related to healthcare inequities in LMICs and hinders equitable access to safe and effective treatments.2Those living in LMICs....
In Celebrating 175 Years, Pfizer Challenges Itself to ‘Outdo Yesterday’
Image caption: Site of the Pfizer World Headquarters Building as it Appeared in 1861It started with a breakthrough.The year was 1849, and people everywhere were getting sick to their stomachs. In the days before widespread refrigeration, a simple meal of meat and potatoes could cause intestinal worms. A drug called santonin could kill the parasites, but it tasted so bitter many people avoided it.Charles Pfizer and his cousin, Charles Erhart, had just immigrated to the U.S. from Germany and....
Pfizer's Multicultural Health Equity Collective Marks 10 Years of Progress
Marginalized communities in the United States have faced generations of health inequities due to systemic discrimination embedded into our healthcare system. Life expectancy in the U.S., for instance, masks significant racial and ethnic disparities – the average life expectancy for non-Hispanic American Indians or Alaska Natives is seven years lower than it is for non-Hispanic whites.1
Advocacy, Strength, and Hope in the Face of Metastatic Melanoma: Bruce and Chris's Story
In 2013, Bruce’s life changed. He was living in sunny Florida with Chris, his wife of over 20 years, when he received an unexpected diagnosis: metastatic melanoma—the most aggressive form of skin cancer.1,2It was a disease Bruce had heard of before—a disease that will impact over 100,000 people in the U.S. this year and 510,000 people across the world by 2040.2,3 But it didn’t cross his mind when he noticed a small lesion on the top of his foot. Chris encouraged Bruce to get it checked out. In....
Behind the Science Features
Understanding Obesity as a Complex Disease
Some people think obesity is simply caused by unhealthy eating habits and not exercising enough. But, in fact, the scientific and medical community defines obesity as a complex, multifactoral chronic disease.
Gene Therapy Myth Busting Quiz
Pfizer experts discuss some of the myths that persist about how gene therapy treatments work and what they can potentially do. Can you separate fact from fiction?
Understanding Pfizer’s Product Pipeline
Pfizer’s product pipeline is a summary of the investigational medicines and vaccines that we’re currently researching and testing, but it can mean so much more. Here’s what it is and why you should care.
Subscriptions
Sign up for communications from Pfizer
Receive the latest news from Pfizer in our monthly The Breakthrough newsletter and email alerts on a variety of topics.
Sign Up Now Details
Newsroom
The latest media resources from Pfizer
Working journalist? Visit the Pfizer Newsroom for our complete library of news, announcements and multimedia assets.
Read More Details